CARBALIVE-488712 The gut-liver axis in liver disease: Pathophysiological basis for therapy | ERD

Search

Associated projects

CARBALIVE - Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.

Organisations

Not specified